J. Slingerland
Molecular Biology · 2000–2017
A researcher in the Science corpus: 7 papers; trusts 2 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 72 citations into it; #9,917 of 17,773 by trust here, #4,273 by citations
- Oncology — 53 citations into it; #612 of 1,698 by trust here, #520 by citations
Whom J. Slingerland trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Slingerland overall
Papers from J. Slingerland's perspective
Ordered by how strongly the researchers J. Slingerland trusts endorse each paper. Same corpus, a different order for every researcher.
- TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
- The phosphoinositide 3-kinase pathway. (Science)
- LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 (EMBO Journal)
- Molecular portraits of human breast tumours (Nature)
- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
- The Pezcoller lecture: cancer cell cycles revisited. (Cancer Research)
- Forkhead Transcription Factor FKHR-L1 Modulates Cytokine-Dependent Transcriptional Regulation of p27KIP1 (Molecular and Cellular Biology)
- G1 cell-cycle control and cancer (Nature)
- Growth factor regulation of autophagy and cell survival in the absence of apoptosis. (Cell)
Their papers
- The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis (2007) — 893 citations
- PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest (2002) — 1,010 citations
- Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. (2014) — 755 citations
- Regulation of the Cdk inhibitor p27 and its deregulation in cancer (2000) — 779 citations
- The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy (2008) — 1,048 citations
- Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention (2017) — 783 citations
- Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression (2003) — 917 citations